Table 1.
Measures and timing of data collection for stage 3 randomized controlled trial.
| Outcomes | Baseline (during the third trimester) | 4, 8, and 12 weeks postpartum | |
| Demographic characteristics | |||
|
|
Age | ✓a | N/Ab |
|
|
Education level | ✓ | N/A |
|
|
Marital status | ✓ | N/A |
|
|
Time in OATc program | ✓ | N/A |
|
|
Number and age of living children | ✓ | N/A |
|
|
Employment | ✓ | N/A |
| Baseline characteristics | |||
|
|
Addiction Severity Index-Lite | ✓ | N/A |
|
|
Maternal Antenatal Attachment Scale | ✓ | N/A |
| Outcome measures | |||
|
|
Addiction Severity Index-Lite | ✓ | ✓ |
|
|
Maternal Postpartum Attachment Scale | N/A | ✓ |
|
|
Birth Satisfaction Scale-Revised | N/A | ✓ |
|
|
Patient Health Questionnaire-9 | N/A | ✓ |
|
|
Parenting Stress Index | N/A | ✓ |
|
|
Client Satisfaction Questionnaire-8 | N/A | ✓ |
|
|
System Usability Scale | N/A | ✓ |
|
|
Length of hospital stay for newborn | N/A | ✓ |
|
|
Newborn hospital readmission | N/A | ✓ |
|
|
Breastfeeding initiation and duration | N/A | ✓ |
|
|
Maternal OAT continuation and relapse | N/A | ✓ |
|
|
Frequency of NASd tool use (weekly) | ✓ | ✓ |
aData collected.
bN/A: not applicable.
cOAT: opioid agonist therapy.
dNAS: neonatal abstinence syndrome.